Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shah Sujal | Chief Executive Officer | Mar 13 '24 | Option Exercise | 4.72 | 139,119 | 655,959 | 406,670 | Mar 15 04:03 PM | Quinlan Paul T | General Counsel | Mar 13 '24 | Option Exercise | 7.89 | 41,824 | 329,991 | 70,262 | Mar 15 04:02 PM | Dorling Janet | Director | Feb 12 '24 | Option Exercise | 4.63 | 6,000 | 27,780 | 6,000 | Feb 14 06:43 PM | Dorling Janet | Director | Feb 12 '24 | Sale | 31.97 | 6,000 | 191,849 | 0 | Feb 14 06:43 PM | McWherter Charles | President of R&D | Jan 19 '24 | Option Exercise | 7.09 | 18,403 | 130,522 | 23,334 | Jan 22 06:59 PM | McWherter Charles | President of R&D | Jan 19 '24 | Sale | 23.67 | 18,403 | 435,645 | 15,000 | Jan 22 06:59 PM | Menold Daniel | Vice President, Finance | Jan 16 '24 | Option Exercise | 4.05 | 10,000 | 40,500 | 10,000 | Jan 16 07:07 PM | Quinlan Paul T | General Counsel | Jan 16 '24 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Jan 16 07:07 PM | Menold Daniel | Vice President, Finance | Jan 16 '24 | Sale | 23.58 | 10,000 | 235,806 | 0 | Jan 16 07:07 PM | Quinlan Paul T | General Counsel | Jan 16 '24 | Sale | 23.58 | 5,000 | 117,898 | 0 | Jan 16 07:07 PM | Dorling Janet | Director | Jan 10 '24 | Option Exercise | 4.63 | 6,000 | 27,780 | 6,000 | Jan 10 08:35 PM | Dorling Janet | Director | Jan 10 '24 | Sale | 23.86 | 6,000 | 143,144 | 0 | Jan 10 08:35 PM | McWherter Charles | President of R&D | Dec 18 '23 | Option Exercise | 5.00 | 11,332 | 56,660 | 21,504 | Dec 18 08:04 PM | McWherter Charles | President of R&D | Dec 18 '23 | Sale | 21.48 | 11,332 | 243,441 | 15,000 | Dec 18 08:04 PM | Menold Daniel | Vice President, Finance | Dec 15 '23 | Option Exercise | 6.39 | 21,497 | 137,420 | 11,497 | Dec 15 04:38 PM | Quinlan Paul T | General Counsel | Dec 15 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Dec 15 04:35 PM | Menold Daniel | Vice President, Finance | Dec 15 '23 | Sale | 21.99 | 21,497 | 472,646 | 0 | Dec 15 04:38 PM | Quinlan Paul T | General Counsel | Dec 15 '23 | Sale | 21.98 | 5,000 | 109,902 | 0 | Dec 15 04:35 PM | Shah Sujal | Chief Executive Officer | Dec 11 '23 | Option Exercise | 5.00 | 64,865 | 324,325 | 235,276 | Dec 11 07:03 PM | Dorling Janet | Director | Dec 11 '23 | Option Exercise | 4.63 | 6,000 | 27,780 | 6,000 | Dec 11 07:01 PM | Shah Sujal | Chief Executive Officer | Dec 11 '23 | Sale | 20.00 | 64,865 | 1,297,170 | 171,301 | Dec 11 07:03 PM | Dorling Janet | Director | Dec 11 '23 | Sale | 20.07 | 6,000 | 120,422 | 0 | Dec 11 07:01 PM | McWherter Charles | President of R&D | Nov 17 '23 | Option Exercise | 5.00 | 11,342 | 56,710 | 26,342 | Nov 17 05:58 PM | McWherter Charles | President of R&D | Nov 17 '23 | Sale | 18.28 | 11,342 | 207,293 | 15,000 | Nov 17 05:58 PM | Menold Daniel | Vice President, Finance | Nov 15 '23 | Option Exercise | 3.45 | 17,500 | 60,375 | 17,500 | Nov 17 05:57 PM | Quinlan Paul T | General Counsel | Nov 15 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Nov 17 05:57 PM | Quinlan Paul T | General Counsel | Nov 15 '23 | Sale | 17.38 | 5,000 | 86,889 | 0 | Nov 17 05:57 PM | McWherter Charles | President of R&D | Oct 18 '23 | Option Exercise | 5.00 | 21,743 | 108,715 | 36,743 | Oct 18 06:22 PM | McWherter Charles | President of R&D | Oct 18 '23 | Sale | 14.07 | 21,743 | 305,941 | 15,000 | Oct 18 06:22 PM | Menold Daniel | Vice President, Finance | Oct 16 '23 | Option Exercise | 3.45 | 17,500 | 60,375 | 17,500 | Oct 18 06:22 PM | Quinlan Paul T | General Counsel | Oct 16 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Oct 18 06:21 PM | Quinlan Paul T | General Counsel | Oct 16 '23 | Sale | 13.76 | 5,000 | 68,798 | 0 | Oct 18 06:21 PM | Shah Sujal | Chief Executive Officer | Oct 09 '23 | Option Exercise | 5.00 | 64,861 | 324,305 | 236,162 | Oct 10 05:04 PM | Shah Sujal | Chief Executive Officer | Oct 09 '23 | Sale | 14.20 | 64,861 | 921,286 | 171,301 | Oct 10 05:04 PM | EMSTER KURT VON | Director | Sep 29 '23 | Option Exercise | 5.00 | 15,921 | 79,605 | 105,921 | Sep 29 05:54 PM | EMSTER KURT VON | Director | Sep 29 '23 | Sale | 15.68 | 15,921 | 249,675 | 90,000 | Sep 29 05:54 PM | McWherter Charles | President of R&D | Sep 18 '23 | Option Exercise | 5.00 | 21,746 | 108,730 | 36,746 | Sep 19 05:27 PM | McWherter Charles | President of R&D | Sep 18 '23 | Sale | 16.22 | 21,746 | 352,733 | 15,000 | Sep 19 05:27 PM | Quinlan Paul T | General Counsel | Sep 15 '23 | Option Exercise | 2.94 | 53,000 | 155,820 | 24,000 | Sep 19 05:23 PM | Menold Daniel | Vice President, Finance | Sep 15 '23 | Option Exercise | 1.73 | 16,545 | 28,612 | 15,000 | Sep 19 05:25 PM | Quinlan Paul T | General Counsel | Sep 15 '23 | Sale | 16.87 | 53,000 | 894,141 | 0 | Sep 19 05:23 PM | McWherter Charles | President of R&D | Aug 18 '23 | Option Exercise | 5.00 | 21,746 | 108,730 | 36,746 | Aug 18 07:03 PM | McWherter Charles | President of R&D | Aug 18 '23 | Sale | 11.47 | 21,746 | 249,359 | 15,000 | Aug 18 07:03 PM | Menold Daniel | Vice President, Finance | Aug 15 '23 | Option Exercise | 5.10 | 15,500 | 79,010 | 8,500 | Aug 16 04:59 PM | Quinlan Paul T | General Counsel | Aug 15 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Aug 16 04:57 PM | Quinlan Paul T | General Counsel | Aug 15 '23 | Sale | 11.91 | 5,000 | 59,550 | 0 | Aug 16 04:57 PM | Menold Daniel | Vice President, Finance | Aug 09 '23 | Option Exercise | 5.00 | 20,945 | 104,725 | 20,945 | Aug 11 06:26 PM | Menold Daniel | Vice President, Finance | Aug 09 '23 | Sale | 12.35 | 20,945 | 258,744 | 0 | Aug 11 06:26 PM | McWherter Charles | President of R&D | Jul 18 '23 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | Jul 19 06:05 PM | McWherter Charles | President of R&D | Jul 18 '23 | Sale | 11.43 | 21,749 | 248,519 | 15,000 | Jul 19 06:05 PM | Quinlan Paul T | General Counsel | Jul 14 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Jul 14 06:52 PM | Quinlan Paul T | General Counsel | Jul 14 '23 | Sale | 11.81 | 5,000 | 59,050 | 0 | Jul 14 06:52 PM | Quinlan Paul T | General Counsel | Jun 30 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | Jun 30 04:51 PM | Quinlan Paul T | General Counsel | Jun 30 '23 | Sale | 10.05 | 5,000 | 50,250 | 0 | Jun 30 04:51 PM | McWherter Charles | President of R&D | Jun 20 '23 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | Jun 21 06:46 PM | McWherter Charles | President of R&D | Jun 20 '23 | Sale | 8.16 | 21,749 | 177,383 | 15,000 | Jun 21 06:46 PM | McWherter Charles | President of R&D | May 18 '23 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | May 19 06:00 PM | McWherter Charles | President of R&D | May 18 '23 | Sale | 9.08 | 21,749 | 197,387 | 15,000 | May 19 06:00 PM | Quinlan Paul T | General Counsel | May 15 '23 | Option Exercise | 2.94 | 5,000 | 14,700 | 5,000 | May 17 07:11 PM | Quinlan Paul T | General Counsel | May 15 '23 | Sale | 10.37 | 5,000 | 51,831 | 0 | May 17 07:11 PM | KIM DENNIS D | Chief Medical Officer | Apr 17 '23 | Option Exercise | 4.37 | 112,219 | 490,397 | 132,219 | Apr 17 07:24 PM | KIM DENNIS D | Chief Medical Officer | Apr 17 '23 | Sale | 9.54 | 112,219 | 1,070,536 | 20,000 | Apr 17 07:24 PM | KIM DENNIS D | Chief Medical Officer | Apr 13 '23 | Option Exercise | 4.37 | 7,781 | 34,003 | 27,781 | Apr 17 07:24 PM | KIM DENNIS D | Chief Medical Officer | Apr 13 '23 | Sale | 8.98 | 7,781 | 69,880 | 20,000 | Apr 17 07:24 PM |
|